Security key
249845504
Dermata Therapeutics, Inc. - Common Stock, Par Value $0.0001 Per Share. (DRMA)
CUSIP: 249845504
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, Par Value $0.0001 Per Share.
- Shares outstanding
- 4,015,532
- Total 13F shares
- 26,892
- Share change
- -65,340
- Total reported value
- $62,390
- Price per share
- $2.32
- Number of holders
- 7
- Value change
- -$372,054
- Number of buys
- 5
- Number of sells
- 2
Report period
Q4 2025
Institutions
7
Top holders
7
DRMA full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Dermata Therapeutics, Inc. SEC filings
Dermata Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 249845504
Recent filing periods:
Top shareholders of DRMA - Dermata Therapeutics, Inc. - Common Stock, Par Value $0.0001 Per Share. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PROEHL GERALD T |
13D/G
|
— |
13%
|
804,098
|
$619,155 | $0 | 27 Mar 2025 | |
| BIGGER CAPITAL FUND L P |
13D/G
|
Bigger Michael |
9.9%
|
300,103
|
$89,401 | +$30,551 | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
5%
from 13D/G
|
81,654
|
$409,903 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
16%
|
476,110
|
$349,941 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
9.4%
|
284,371
|
$209,041 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
1.7%
|
50,127
|
$36,848 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
39,073
|
$28,723 | — | 30 Sep 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
1.2%
|
36,561
|
$26,876 | — | 30 Sep 2025 | |
| INTEGRITY WEALTH ADVISORS, INC. |
13F
|
Company |
0.93%
|
28,209
|
$20,736 | — | 30 Sep 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.86%
|
26,220
|
$19,000 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.56%
|
16,866
|
$12,398 | — | 30 Sep 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.35%
|
10,510
|
$8,000 | — | 30 Sep 2025 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.05%
|
1,428
|
$1,000 | — | 30 Sep 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
142
|
$103 | — | 30 Sep 2025 | |
| Atlantic Union Bankshares Corp |
13F
|
Company |
0%
|
122
|
$90 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
103
|
$76 | — | 30 Sep 2025 | |
| Proehl Investment Ventures LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
2,933,531
mixed-class rows
|
$6,973,306 | — | 17 Aug 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
—
mixed-class rows
|
118,762
mixed-class rows
|
$80,047 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
12,000
|
$60,240 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
22,457
mixed-class rows
|
$58,639 | — | 30 Sep 2025 | |
| Thomas Insley |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
14,337
|
$34,409 | — | 17 Aug 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
mixed-class rows
|
5,581
mixed-class rows
|
$5,928 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
—
mixed-class rows
|
2,165
mixed-class rows
|
$2,024 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
37
mixed-class rows
|
$44 | — | 30 Sep 2025 |
Institutional Holders of Dermata Therapeutics, Inc. - Common Stock, Par Value $0.0001 Per Share. (DRMA) as of Q4 2025
As of 31 Dec 2025,
Dermata Therapeutics, Inc. - Common Stock, Par Value $0.0001 Per Share. (DRMA) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,892 shares.
The largest 7 holders included
Clear Street Group Inc., BANK OF AMERICA CORP /DE/, BARCLAYS PLC, Tower Research Capital LLC (TRC), UBS Group AG, JPMORGAN CHASE & CO, and SBI Securities Co., Ltd..
This page lists
7
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
5
Q4 2025 holders
7
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.